68Ga-OncoFAP

gallium-68 labelled OncoFAP derivative · Philogen S.p.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 68Ga-OncoFAP, covering 2024-11-15 to 2024-11-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Dosimetry of 68Ga-labelled OncoFAP Derivatives in Solid Tumors [Phase 1]